All Stories

  1. Clinical prediction scores to help in the screening of Ebola virus disease suspects

    Article • PLoS ONE, December 2022, PLOS

    Lut Lynen, Antoine Oloma Tshomba

  2. Appropriateness of Antibiotic Prescribing for Acute Conjunctivitis: A Cross-Sectional Study at a Specialist Eye Hospital in Ghana, 2021

    Article • International Journal of Environmental Research and Public Health, September 2022, MDPI AG

    Lut Lynen

  3. Person‐centred care and short oral treatment for rifampicin‐resistant tuberculosis improve retention in care in Kandahar, Afghanistan

    Article • Tropical Medicine & International Health, January 2022, Wiley

    Lut Lynen

  4. Pretomanid for tuberculosis: a systematic review

    Article • Clinical Microbiology and Infection, January 2022, Elsevier

    Lut Lynen

  5. Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: A retrospective cohort study

    Article • PLoS ONE, November 2021, PLOS

    Lut Lynen

  6. Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia

    Article • World Journal of Hepatology, September 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Lut Lynen

  7. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial

    Article • The Lancet Infectious Diseases, May 2021, Elsevier

    Lut Lynen

  8. Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis

    Article • AIDS Research and Therapy, April 2021, Springer Science + Business Media

    Lut Lynen

  9. Diagnostic Accuracy of the INSHI Consensus Case Definition for the Diagnosis of Paradoxical Tuberculosis-IRIS

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2021, Wolters Kluwer Health

    Lut Lynen

  10. Case Report: Therapeutic Threshold for Rifampicin-Resistant Tuberculosis in a Patient from Maputo, Mozambique

    Article • American Journal of Tropical Medicine and Hygiene, April 2021, American Society of Tropical Medicine and Hygiene

    Lut Lynen

  11. Human rights: finding the right balance for rifampicin-resistant TB treatment

    Article • The International Journal of Tuberculosis and Lung Disease, April 2021, International Union Against Tuberculosis and Lung Disease

    Lut Lynen

  12. Finding the right balance between efficacy and tolerability for TB treatment: the search continues

    Article • The International Journal of Tuberculosis and Lung Disease, January 2021, International Union Against Tuberculosis and Lung Disease

    Lut Lynen

  13. Hepatitis C Prevalence and Validation of a Clinical Prediction Score for Targeted Screening among People Living with HIV in Ghana

    Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), January 2021, SAGE Publications

    Lut Lynen

  14. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV “Treat All” in Zimbabwe

    Article • PLoS ONE, October 2020, PLOS

    Lut Lynen

  15. Comparison of first-line tuberculosis treatment outcomes between previously treated and new patients: a retrospective study in Machakos subcounty, Kenya

    Article • International Health, August 2020, Oxford University Press (OUP)

    Lut Lynen

  16. District-level strategies to control the HIV epidemic in Zimbabwe: a practical example of precision public health

    Article • BMC Research Notes, August 2020, Springer Science + Business Media

    Lut Lynen

  17. Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study

    Article • PLoS ONE, August 2020, PLOS

    Lut Lynen

  18. Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study

    Article • PLoS ONE, August 2020, PLOS

    Lut Lynen

  19. High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    Dr Mahamadou Bassirou Souleymane, Lut Lynen

  20. False Rifampicin Resistance in Xpert Ultra Applied to Lymph Node Aspirate: A Case Report

    Article • Open Forum Infectious Diseases, June 2020, Oxford University Press (OUP)

    Lut Lynen

  21. Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia

    Article • Infectious Diseases and Therapy, May 2020, Springer Science + Business Media

    Lut Lynen

  22. The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance

    Article • PLoS ONE, May 2020, PLOS

    Lut Lynen

  23. First-line tuberculosis treatment with double-dose rifampicin is well tolerated

    Article • The International Journal of Tuberculosis and Lung Disease, May 2020, International Union Against Tuberculosis and Lung Disease

    Lut Lynen

  24. Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia

    Article • BMC Infectious Diseases, March 2020, Springer Science + Business Media

    Lut Lynen

  25. High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis

    Article • American Journal of Respiratory and Critical Care Medicine, March 2020, American Thoracic Society

    Lut Lynen

  26. Tuberculosis treatment: one-shot approach or cascade of regimens?

    Article • The Lancet Respiratory Medicine, February 2020, Elsevier

    Lut Lynen

  27. Decision-making in the diagnosis of tuberculous meningitis

    Article • Wellcome Open Research, January 2020, Faculty of 1000, Ltd.

    Lut Lynen

  28. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015

    Article • PLoS ONE, January 2020, PLOS

    Lut Lynen

  29. The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    Cari Stek, Lut Lynen

  30. Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis: a descriptive retrospective study in Belgium

    Article • Acta Clinica Belgica, September 2019, Taylor & Francis

    Chris Kenyon, Lut Lynen

  31. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s National Antiretroviral Therapy Programme between 2012 and 2015

    Article • August 2019, Cold Spring Harbor Laboratory Press

    Lut Lynen

  32. Temporary disengagement and re-engagement in human immunodeficiency virus care in a rural county serving pastoralist communities in Kenya: a retrospective cohort study

    Article • International Health, June 2019, Oxford University Press (OUP)

    Lut Lynen

  33. Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study

    Article • International Health, February 2019, Oxford University Press (OUP)

    Lut Lynen

  34. Viral load detection and management on first line ART in rural Rwanda

    Article • BMC Infectious Diseases, January 2019, Springer Science + Business Media

    Lut Lynen

  35. Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study

    Article • Global Health Action, January 2019, Taylor & Francis

    Lut Lynen

  36. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS

    Article • New England Journal of Medicine, November 2018, New England Journal of Medicine (NEJM/MMS)

    Lut Lynen, Prof Robert Colebunders

  37. The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy

    Article • Frontiers in Microbiology, October 2018, Frontiers

    Lut Lynen

  38. Development of a clinical prediction score for targeted hepatitis C screening in a low-risk HIV cohort in Cambodia

    Article • Journal of Hepatology, April 2018, Elsevier

    Lut Lynen

  39. Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs

    Article • The International Journal of Tuberculosis and Lung Disease, March 2018, International Union Against Tuberculosis and Lung Disease

    Lut Lynen

  40. What Is the Role of Paired Rapid Plasma Reagin Testing (Simultaneous Testing of Acute and Convalescent Samples) in the Diagnosis of Repeat Syphilis and the Follow-up of Syphilis?

    Article • Sexually Transmitted Diseases, January 2018, Wolters Kluwer Health

    Lut Lynen

  41. Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study

    Article • Journal of Antimicrobial Chemotherapy, December 2017, Oxford University Press (OUP)

    Lut Lynen

  42. Unexpected Infection with Armillifer Parasites

    Article • Emerging Infectious Diseases, December 2017, Centers for Disease Control and Prevention (CDC)

    Lut Lynen

  43. Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes

    Article • PLoS ONE, November 2017, PLOS

    Lut Lynen

  44. Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold

    Article • BMC Infectious Diseases, October 2017, Springer Science + Business Media

    Aquiles Rodrigo Henriquez-Trujillo, Lut Lynen

  45. A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening

    Article • PLoS ONE, August 2017, PLOS

    Lut Lynen

  46. Performance of the Antiretroviral Treatment Program in Ethiopia, 2005-2015: strengths and weaknesses toward ending AIDS

    Article • International Journal of Infectious Diseases, July 2017, Elsevier

    Lut Lynen

  47. Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia

    Article • PLoS ONE, June 2017, PLOS

    Lut Lynen, Prof Robert Colebunders

  48. Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies

    Article • New England Journal of Medicine, December 2016, New England Journal of Medicine (NEJM/MMS)

    Lut Lynen

  49. Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015

    Article • Emerging Infectious Diseases, December 2016, Centers for Disease Control and Prevention (CDC)

    Lut Lynen

  50. Diagnosis of Visceral Leishmaniasis Using Peripheral Blood Microscopy in Ethiopia: A Prospective Phase-III Study of the Diagnostic Performance of Different Concentration Techniques Compared to Tissue Aspiration

    Article • American Journal of Tropical Medicine and Hygiene, October 2016, American Society of Tropical Medicine and Hygiene

    Lut Lynen

  51. Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint

    Article • Tropical Medicine & International Health, October 2016, Wiley

    Lut Lynen

  52. Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea

    Article • American Journal of Tropical Medicine and Hygiene, September 2016, American Society of Tropical Medicine and Hygiene

    Lut Lynen

  53. Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

    Article • JMIR Research Protocols, August 2016, JMIR Publications Inc.

    Lut Lynen, Prof Robert Colebunders

  54. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients

    Article • Cytometry Part B Clinical Cytometry, March 2016, Wiley

    Lut Lynen

  55. Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak

    Article • Clinical Trials, February 2016, SAGE Publications

    Lut Lynen

  56. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

    Article • New England Journal of Medicine, January 2016, New England Journal of Medicine (NEJM/MMS)

    Lut Lynen, Prof Robert Colebunders

  57. Factors associated with prevalent tuberculosis among patients receiving highly active antiretroviral therapy in a Nigerian tertiary hospital

    Article • Annals of Medical and Health Sciences Research, January 2016, Medknow

    Lut Lynen

  58. Usefulness of Common Fibrosis Markers to Predict Viremia in Patients with Reactive Hepatitis C Antibody Test

    Article • Journal of Hepatology, January 2016, Elsevier

    Lut Lynen

  59. Brief Report

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2015, Wolters Kluwer Health

    Lut Lynen

  60. Systematic screening for drug-resistant tuberculosis with Xpert® MTB/RIF in a referral hospital in Cambodia

    Article • The International Journal of Tuberculosis and Lung Disease, December 2015, International Union Against Tuberculosis and Lung Disease

    Lut Lynen, Prof Robert Colebunders

  61. Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in Cambodia

    Article • PLoS ONE, November 2015, PLOS

    Lut Lynen

  62. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy

    Article • Tropical Medicine & International Health, October 2015, Wiley

    Lut Lynen

  63. Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study

    Article • PLoS Neglected Tropical Diseases, October 2015, PLOS

    Lut Lynen, Prof Robert Colebunders

  64. The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field

    Article • Clinical Infectious Diseases, August 2015, Oxford University Press (OUP)

    Lut Lynen, Prof Robert Colebunders

  65. Challenges from Tuberculosis Diagnosis to Care in Community-Based Active Case Finding among the Urban Poor in Cambodia: A Mixed-Methods Study

    Article • PLoS ONE, July 2015, PLOS

    Lut Lynen, Prof Robert Colebunders

  66. Impact of the Use of a Rapid Diagnostic Test for Visceral Leishmaniasis on Clinical Practice in Ethiopia: A Retrospective Study

    Article • PLoS Neglected Tropical Diseases, May 2015, PLOS

    Lut Lynen

  67. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    Article • PLoS Medicine, March 2015, PLOS

    Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Lut Lynen, Hugh Montgomery, Prof Robert Colebunders

  68. Is frontloaded sputum microscopy an option in active tuberculosis case finding?

    Article • The International Journal of Tuberculosis and Lung Disease, January 2015, International Union Against Tuberculosis and Lung Disease

    Lut Lynen, Prof Robert Colebunders

  69. Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings

    Article • The Lancet Infectious Diseases, January 2015, Elsevier

    Lut Lynen, Prof Robert Colebunders

  70. Syphilis reinfections pose problems for syphilis diagnosis in Antwerp, Belgium – 1992 to 2012

    Article • Eurosurveillance, November 2014, European Centre for Disease Control and Prevention (ECDC)

    Lut Lynen

  71. Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART-1 study

    Article • Journal of the International AIDS Society, November 2014, Wiley

    Lut Lynen

  72. Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia

    Article • Tropical Medicine & International Health, October 2014, Wiley

    Lut Lynen

  73. Active tuberculosis screening of close contacts among the urban poor: a Cambodian experience

    Article • The International Journal of Tuberculosis and Lung Disease, October 2014, International Union Against Tuberculosis and Lung Disease

    Lut Lynen

  74. A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV-Infected Individuals in Endemic East African Countries: The Way Forward?

    Article • PLoS Neglected Tropical Diseases, August 2014, PLOS

    Lut Lynen

  75. Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines

    Article • PLoS Neglected Tropical Diseases, July 2014, PLOS

    Lut Lynen

  76. Visceral Leishmaniasis and HIV Coinfection in East Africa

    Article • PLoS Neglected Tropical Diseases, June 2014, PLOS

    Lut Lynen

  77. High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia

    Article • PLoS Neglected Tropical Diseases, May 2014, PLOS

    Lut Lynen

  78. Exploring three approaches to offer distance learning courses through a social network of health researchers in three African countries

    Article • May 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Lut Lynen

  79. Leishmaniasis in immunosuppressed individuals

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Lut Lynen

  80. A Clinical Prediction Score for Targeted Creatinine Testing Before Initiating Tenofovir-Based Antiretroviral Treatment in Cambodia

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2014, Wolters Kluwer Health

    Lut Lynen

  81. Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia

    Article • International Journal of Infectious Diseases, April 2014, Elsevier

    Lut Lynen

  82. Community-Based Active Tuberculosis Case Finding in Poor Urban Settlements of Phnom Penh, Cambodia: A Feasible and Effective Strategy

    Article • PLoS ONE, March 2014, PLOS

    Lut Lynen, Prof Robert Colebunders

  83. Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in Cambodia

    Article • PLoS ONE, February 2014, PLOS

    Lut Lynen

  84. Simplified Clinical Prediction Scores to Target Viral Load Testing in Adults with Suspected First Line Treatment Failure in Phnom Penh, Cambodia

    Article • PLoS ONE, February 2014, PLOS

    Lut Lynen

  85. How to improve patient retention in an antiretroviral treatment program in Ethiopia: a mixed-methods study

    Article • BMC Health Services Research, January 2014, Springer Science + Business Media

    Lut Lynen

  86. Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013

    Article • Globalization and Health, January 2014, Springer Science + Business Media

    Lut Lynen

  87. Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Lut Lynen

  88. Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine

    Article • The Journal of Infectious Diseases, June 2013, Oxford University Press (OUP)

    Lut Lynen

  89. Rapid diagnostic tests for neurological infections in central Africa

    Article • The Lancet Infectious Diseases, June 2013, Elsevier

    Lut Lynen

  90. Validation of a Clinical Prediction Score to Target Viral Load Testing in Adults With Suspected First-Line Treatment Failure in Resource-Constrained Settings

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2013, Wolters Kluwer Health

    Lut Lynen

  91. Bloodstream Infection among Adults in Phnom Penh, Cambodia: Key Pathogens and Resistance Patterns

    Article • PLoS ONE, March 2013, PLOS

    Lut Lynen

  92. Risk Factors of Treatment-Limiting Anemia after Substitution of Zidovudine for Stavudine in HIV-Infected Adult Patients on Antiretroviral Treatment

    Article • PLoS ONE, March 2013, PLOS

    Lut Lynen

  93. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 2013, Oxford University Press (OUP)

    Lut Lynen

  94. Azithromycin and Ciprofloxacin Resistance in Salmonella Bloodstream Infections in Cambodian Adults

    Article • PLoS Neglected Tropical Diseases, December 2012, PLOS

    Lut Lynen

  95. Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines

    Article • Bulletin of the World Health Organization, December 2012, WHO Press

    Lut Lynen

  96. Short and long term retention in antiretroviral care in health facilities in rural Malawi and Zimbabwe

    Article • BMC Health Services Research, December 2012, Springer Science + Business Media

    Lut Lynen

  97. Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years?

    Article • Expert Review of Anti-infective Therapy, November 2012, Taylor & Francis

    Lut Lynen, Prof Robert Colebunders

  98. A Clinical Prediction Score in Addition to WHO Criteria for Anti-Retroviral Treatment Failure in Resource-Limited Settings - Experience from Lesotho

    Article • PLoS ONE, October 2012, PLOS

    Lut Lynen

  99. Adoption of new HIV treatment guidelines and drug substitutions within first-line as a measure of quality of care in rural Lesotho: health centers and hospitals compared

    Article • Tropical Medicine & International Health, July 2012, Wiley

    Lut Lynen

  100. Staphylococcus aureus blood stream infections in Cambodian adults

    Article • International Journal of Infectious Diseases, June 2012, Elsevier

    Lut Lynen

  101. Incidence of Treatment-Limiting Toxicity with Stavudine-Based Antiretroviral Therapy in Cambodia: A Retrospective Cohort Study

    Article • PLoS ONE, January 2012, PLOS

    Lut Lynen

  102. Is increasing complexity of algorithms the price for higher accuracy? virtual comparison of three algorithms for tertiary level management of chronic cough in people living with HIV in a low-income country

    Article • BMC Medical Informatics and Decision Making, January 2012, Springer Science + Business Media

    Lut Lynen

  103. Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa

    Article • AIDS, August 2011, Wolters Kluwer Health

    Lut Lynen

  104. Genotypic Impact of Prolonged Detectable HIV Type 1 RNA Viral Load after HAART Failure in a CRF01_AE-Infected Cohort

    Article • AIDS Research and Human Retroviruses, July 2011, Mary Ann Liebert Inc

    Lut Lynen

  105. Melioidosis, Phnom Penh, Cambodia

    Article • July 2011, Centers for Disease Control and Prevention (CDC)

    Lut Lynen

  106. Determination of Kidney Function Before Tenofovir Initiation: Four-Fold Difference in Need of Tenofovir Dose Reduction Depending on Method Used

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2011, Wolters Kluwer Health

    Lut Lynen

  107. Challenges in developing national HIV guidelines: experience from the eastern Mediterranean

    Article • Bulletin of the World Health Organization, April 2011, WHO Press

    Lut Lynen

  108. Evaluation of the 2007 WHO Guideline to Improve the Diagnosis of Tuberculosis in Ambulatory HIV-Positive Adults

    Article • PLoS ONE, April 2011, PLOS

    Lut Lynen

  109. Performance of Abdominal Ultrasound for Diagnosis of Tuberculosis in HIV-Infected Persons Living in Cambodia

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2010, Wolters Kluwer Health

    Lut Lynen

  110. A telemedicine service for HIV/AIDS physicians working in developing countries

    Article • Journal of Telemedicine and Telecare, November 2010, SAGE Publications

    Lut Lynen

  111. Time for “Test and Treat” in Prevention of Mother-to-Child Transmission Programs in Low- and Middle-Income Countries

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2010, Wolters Kluwer Health

    Lut Lynen

  112. Challenges in the diagnosis of meningitis in low-resource settings

    Article • Tropical Medicine & International Health, October 2010, Wiley

    Lut Lynen, Prof Robert Colebunders

  113. Attrition of HIV-infected individuals not yet eligible for antiretroviral treatment: do we care?

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, October 2010, Oxford University Press (OUP)

    Lut Lynen

  114. Challenges in HIV and visceral Leishmania co-infection: future research directions

    Article • Tropical Medicine & International Health, August 2010, Wiley

    Lut Lynen

  115. Treatment of HIV infection with drugs for HSV-2 infection – Authors' reply

    Article • The Lancet, July 2010, Elsevier

    Lut Lynen

  116. Combination therapy for visceral leishmaniasis

    Article • The Lancet Infectious Diseases, March 2010, Elsevier

    Lut Lynen

  117. Treating HIV infection with drugs for HSV-2 infection?

    Article • The Lancet, March 2010, Elsevier

    Lut Lynen

  118. Decrease of vitamin D concentration in patients with HIV infection on a Non Nucleoside Reverse Transcriptase Inhibitor containing regimen

    Article • AIDS Research and Therapy, January 2010, Springer Science + Business Media

    Lut Lynen

  119. Mobile learning for HIV/AIDS healthcare worker training in resource-limited settings

    Article • AIDS Research and Therapy, January 2010, Springer Science + Business Media

    Lut Lynen

  120. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings

    Article • Current Opinion in HIV and AIDS, January 2010, Wolters Kluwer Health

    Lut Lynen

  121. Substituting nevirapine for efavirenz: risk factors for toxicity in nonnaive patients in a resource-constrained setting

    Article • AIDS, November 2009, Wolters Kluwer Health

    Lut Lynen

  122. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia

    Article • Tropical Medicine & International Health, July 2009, Wiley

    Lut Lynen, Prof Robert Colebunders

  123. Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead

    Article • AIDS, May 2009, Wolters Kluwer Health

    Lut Lynen, Prof Robert Colebunders

  124. Melioidosis in an Urban Referral Hospital, Phnom Penh, Cambodia

    Article • International Journal of Infectious Diseases, December 2008, Elsevier

    Lut Lynen

  125. Validation of a Manual Blood System and the Distribution of Organisms Causing Bacteremia in a Resource-Limited Setting, SHCH, Phnom Penh, Cambodia

    Article • International Journal of Infectious Diseases, December 2008, Elsevier

    Lut Lynen

  126. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching

    Article • AIDS, October 2008, Wolters Kluwer Health

    Lut Lynen

  127. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

    Article • The Lancet Infectious Diseases, August 2008, Elsevier

    Lut Lynen, Prof Robert Colebunders

  128. Prevention and treatment of the immune reconstitution inflammatory syndrome

    Article • Current Opinion in HIV and AIDS, July 2008, Wolters Kluwer Health

    Lut Lynen

  129. Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, November 2007, Oxford University Press (OUP)

    Lut Lynen, Prof Robert Colebunders

  130. Bridging the gap between clinical practice and diagnostic clinical epidemiology: pilot experiences with a didactic model based on a logarithmic scale

    Article • Journal of Evaluation in Clinical Practice, June 2007, Wiley

    Lut Lynen

  131. HIV Viral Load Monitoring in Resource‐Limited Regions: Optional or Necessary?

    Article • Clinical Infectious Diseases, January 2007, Oxford University Press (OUP)

    Lut Lynen

  132. Validation of Primary CD4 Gating as an Affordable Strategy for Absolute CD4 Counting in Cambodia

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2006, Wolters Kluwer Health

    Lut Lynen

  133. Remote consultations and HIV/AIDS continuing education in low-resource settings

    Article • International Journal of Medical Informatics, September 2006, Elsevier

    Lut Lynen, Prof Robert Colebunders

  134. Authors' reply

    Article • The Lancet Infectious Diseases, July 2006, Elsevier

    Lut Lynen, Prof Robert Colebunders

  135. The Added Value of a CD4 Count to Identify Patients Eligible for Highly Active Antiretroviral Therapy Among HIV-Positive Adults in Cambodia

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2006, Wolters Kluwer Health

    Lut Lynen, Prof Robert Colebunders

  136. Demographic and Clinical Characteristics of HIV-Infected Inpatients and Outpatients at a Cambodian Hospital

    Article • AIDS Patient Care and STDs, May 2006, Mary Ann Liebert Inc

    Lut Lynen

  137. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries

    Article • The Lancet Infectious Diseases, January 2006, Elsevier

    Lut Lynen, Prof Robert Colebunders

  138. Review editorial: Prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment

    Article • Tropical Medicine & International Health, December 2005, Wiley

    Lut Lynen, Prof Robert Colebunders

  139. Comparison of albendazole regimen for prophylaxis of strongyloides hyperinfection in nephrotic syndrome patients on long-term steroids in Cambodia

    Article • Tropical Doctor, October 2005, SAGE Publications

    Lut Lynen

  140. Palliative care in sub-Saharan Africa

    Article • The Lancet, August 2005, Elsevier

    Lut Lynen, Prof Robert Colebunders

  141. Disseminated nocardiosis presenting with cardiac tamponade in an HIV patient

    Article • International Journal of STD & AIDS, December 2004, SAGE Publications

    Lut Lynen

  142. Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?

    Article • International Journal of STD & AIDS, January 2003, SAGE Publications

    Lut Lynen, Prof Robert Colebunders

  143. Do Patents Prevent Access to Drugs for HIV in Developing Countries?

    Article • JAMA, February 2002, American Medical Association (AMA)

    Lut Lynen, Prof Robert Colebunders

  144. Evaluation of two tests based on the detection of histidine rich protein 2 for the diagnosis of imported Plasmodium falciparum malaria

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, May 1998, Oxford University Press (OUP)

    Lut Lynen

  145. Clinical algorithm for malaria in Africa

    Article • The Lancet, May 1996, Elsevier

    Lut Lynen